| 17OHP | 17-hydroxyprogesterone |
| ACMG | American College of Medical Genetics and Genomics |
| ACTH | Adrenocorticotropic hormone |
| AF | Activation function |
| AMH | Anti-Müllerian hormone |
| AMH | Anti-Müllerian hormone |
| Androst | Androstenedione |
| C | Cortisol |
| CAT | Computerized axial tomography |
| CGA | Candidate gene approach |
| DBD | DNA binding domain |
| DHEA-s | Dehydroepiandrosterone sulphate |
| DHT | Dihydrotestosterone |
| DSD | Disorders/differences of sex development |
| E2 | Estradiol |
| F | Female |
| FSH | Follicle-stimulating hormone |
| HA | Hemagglutinin |
| hCG | Human chorionic gonadotropin |
| HGMD. | Human Gene Mutation Database |
| KO | Knockout |
| LBD | Ligand binding domain |
| LH | Luteinizing hormone |
| LHRH | Luteinizing hormone releasing hormone |
| LP | Likely pathogenic |
| M | Male |
| MAF | Minor allele frequency |
| MRI | Magnetic resonance imaging |
| N | Normal |
| ND | Not determined |
| NGS | Next generation sequencing |
| OMIM | Online Mendelian Inheritance in Man |
| PCOS | Polycystic ovary syndrome |
| PCR | Polymerase chain reaction |
| RLU | Relative light units |
| SF1 | Steroidogenic factor 1 |
| T | Testosterone |
| TGP | Targeted gene panel |
| US | Ultrasound |
| Ve | Empty vector |
| VUS | Variant of unknown significance |
| WT | Wild-type |
| Y | Years |
| ZN | Zinc finger domain |